Search

everythinglearnresearchcommunity

for

Search:↓

RHA fillers are effective and safe for treating nasolabial folds in people of color.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tofacitinib may help regrow hair in alopecia areata patients.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

The role of γδT-cells in causing alopecia areata remains unclear.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

RIPK1 inhibitors might help prevent alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

The document's conclusion cannot be provided as the content is not available.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

DA-5512 effectively improves hair growth and health, performing better than minoxidil.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Blocking a protein called prostaglandin D2 might help treat hair loss.

RNase L hinders hair growth by altering immune signals.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.